A Clinical Trial Assessing the Safety and Effectiveness of the DurAVR® THV System | MicrobiomeTrials← Back to trialsNCT07194265
A Clinical Trial Assessing the Safety and Effectiveness of the DurAVR® THV System
RecruitingNAINTERVENTIONAL
Trial Details
Start: 2025-10-21Est. Completion: 2027-12
Enrollment target: 1,650 participants Locations- Rigshospitalet, Copenhagen, Capital Region of Denmark, Denmark
Other microbiome trials you might be interested in
Mesenteric Vascular DiseaseColorectal SurgeryPreventive Intervention
Rationale:
Anastomotic leakage (AL) is a severe complication of colon surgery, with an incidence of 2.7-11.9%. It is as…
Emmen, NetherlandsEst. completion Feb 1, 2028
Aortic AneurysmAortic Aneurysm and DissectionAortic DiseasesAneurysm of Aorta, ThoracicAneurysmal DiseaseAorta, Thoracic Pathologies
The Goal of this Clinical Study is to evaluate the safety and effectiveness of the Rapidlink device in the repair or rep…
Los Angeles, United StatesEst. completion Nov 2027
Aortic Valve StenosisTranscatheter Aortic Valve ImplantationPericapsular Nerve Group BlockFascia Iliaca Block
Aortic Stenosis (AS) is the most common valvular pathology, particularly prevalent in advanced age, and Transcatheter Ao…
Istanbul, Turkey (Türkiye)Est. completion Nov 1, 2026